Showing results (2671-2680 of 10,007) with videos related to
Sort By:
Pageof 1,001
Leukemia & Lymphoma|December 29, 2004
Regulation of CD23 expression by Notch2 in B-cell chronic lymphocytic leukemiaJ D Schwarzmeier, R Hubmann, M Düchler, et al.Leukemia & Lymphoma|December 29, 2004
Prognostic factors in patients with post-transplant lymphoproliferative disorders (PTLD) in the rituximab eraIrene M Ghobrial, Thomas M Habermann, Kay M Ristow, et al.Leukemia & Lymphoma|December 29, 2004
Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART)Timo Wolf, Hans-Reinhard Brodt, Stephan Fichtlscherer, et al.Leukemia & Lymphoma|December 29, 2004
Expression of Polo-Like Kinase (PLK1) in non-Hodgkin's lymphomasKatsuhiko Mito, Kenji Kashima, Hiroshi Kikuchi, et al.Leukemia & Lymphoma|December 29, 2004
The Kasumi-1 cell line: a t(8;21)-kit mutant model for acute myeloid leukemiaLidia Larizza, Ivana Magnani, Alessandro BeghiniLeukemia & Lymphoma|December 29, 2004
AML1/ETO promotes the maintenance of early hematopoietic progenitors in NOD/SCID mice but does not abrogate their lineage specific differentiationJörg Bäsecke, Maike Schwieger, Frank Griesinger, et al.Leukemia & Lymphoma|December 29, 2004
Burkitt's lymphoma presenting with lactic acidosis and hypoglycemia - a case presentationJeffrey J Glasheen, Mathew D SorensenLeukemia & Lymphoma|October 30, 2004
Interferon alpha 2b as maintenance therapy improves outcome in follicular lymphomaAgustin Avilés, Natividad Neri, Judith Huerta-Guzmán, et al.Leukemia & Lymphoma|October 30, 2004
Treatment of relapsed/refractory multiple myeloma with thalidomide-based regimens: identification of prognostic factorsAthanasios Anagnostopoulos, Dimitra Gika, George Hamilos, et al.Pageof 1,001